Authors: OGATA N OGATA Y HOKAMAKI J ARAKI H MORIKAMI Y NUMATA Y

Citation: N. Ogata et al., SERIAL CHANGES OF PLASMINOGEN-ACTIVATOR INHIBITOR ACTIVITY IN THROMBOLYTIC THERAPY FOR ACUTE MYOCARDIAL-INFARCTION - COMPARISON BETWEEN THROMBOLYTIC THERAPIES WITH MUTANT TPA (LANOTEPLASE BMS-200980) AND RECOMBINANT TPA (ALTEPLASE)/, Circulation, 94(8), 1996, pp. 514-514

Authors: OGAWA H YASUE H OSHIMA S OGATA Y NUMATA Y FUJIMOTO K IMOTO N SAITO T HOKAMURA Y TAKAHASHI T WATANABE H KODAMA H MORIKAMI Y MIYAGI H OBATA K MATSUYAMA K SAKAINO N NAKAMURA T WAKITA T

Citation: H. Ogawa et al., EFFECT OF THE INITIAL BOLUS VOLUME OF RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR ON CORONARY RECANALIZATION AND INFARCT SIZE IN JAPANESEACUTE MYOCARDIAL-INFARCTION PATIENTS, Japanese Circulation Journal, 59(10), 1995, pp. 663-672

Authors: MORIKAMI Y HIGASHI T ISOMURA T HIRANO A TANAKA K HISATOMI K OHISHI K

Citation: Y. Morikami et al., CARDIAC LIPOMA WITH CHANCES OF ST-SEGMENT AND T-WAVE ON ELECTROCARDIOGRAM, Japanese Circulation Journal, 58(9), 1994, pp. 733-736